University for Development Studies, Tamale, Ghana Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2005
NCT00238017
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Alternative names

University for Development Studies | University for Development Studies, Tamale, Ghana

Active Ingredients

Drugs in Phase 4 Trials (2)

amodiaquine (camoquin) (1 trial)

artesunate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2